Raw nerve: Drugs may get costlier as prices of ingredients surge 30%
Medicine prices in India may rise sharply amid a 30% surge in the cost of key raw materials…
Ancient herb known as ‘nature’s Valium’ touted for improving sleep and anxiety
Valerian, an herbal supplement long used for sleep and relaxation, has been referred to as “nature’s Valium” —…
GOP Sen. Johnson investigating FDA rare disease drug rejections
WASHINGTON — Sen. Ron Johnson (R-Wis.) said he is investigating the Food and Drug Administration’s rejections of rare disease…
FDA warns Novo Nordisk of potential unreported GLP-1 side effects
The Food and Drug Administration issued a warning letter to Novo Nordisk — the maker of Ozempic and…
Public spending on prescriptions rises to $20.1-billion in 2024 as use of Ozempic grows
Public spending on prescription medications in Canada grew by more than 9 per cent in 2024, with one…
FDA contradicts Trump admin, declines to approve generic drug for autism
In September, the Trump administration took what it called “bold actions” on autism that included touting the generic…
Wegovy users have five times greater risk of sudden sight loss than Ozempic users, study finds | Health
Patients taking Wegovy have nearly five times the risk of sudden sight loss of those on Ozempic, a…
‘Huge wait list’ for ADHD medication amid 87% rise in prescriptions
There is still a “huge wait list” for people seeking medication for ADHD – despite an 87% increase…
Kids can take tablets, so why are we still giving liquid medicines?
When six-year-old Seren was prescribed antibiotics, taking them four times a day quickly became a battle. The orange…
FDA warns Novo Nordisk over unreported potential Ozempic side effects
Novo Nordisk, the pharmaceutical company behind Ozempic, has received a warning letter from the U.S. Food and Drug…
Tylenol use in pregnant women visiting ED dropped after Trump’s unfounded autism claim
Tylenol orders for pregnant women visiting the ED fell 10% (observed-to-expected ratio [OER], 0.90), corresponding to an absolute…
Further Cutting Development Costs by Up to 50%
WASHINGTON, March 10, 2026 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) today released New and Revised…